Market research
7782.TSE Sincere Co., LTD
TSE JPY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- 15.43
- Analyst target
- Not available
- Dividend yield
- 3.4%
- Beta
- 0.5
Profile
Instrument facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- JP3376500009
- Market cap
- 3B
- P/E ratio
- 15.43
- Analyst target
- Not available
- Dividend yield
- 3.4%
- Beta
- 0.5
About
About Sincere Co., LTD
Sincere Co., LTD. manufacture and sells contact lenses in Japan. It operates through three segments: Contact Lens, Consulting, and System business. The company also engages in consulting on medical hair removal clinic management, as well as the design, development, sale, and maintenance of package systems for the reuse industry. In addition, it provides management support for medical institutions, medical related businesses, and elderly facility management. The company was incorporated in 2008 and is headquartered in Tokyo, Japan.
Research context
Sincere Co., LTD appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 7782.TSE discussion.
5 years, 6 months ago
Sincere Co., LTD is currently in a long term downtrend where the price is trading 0.2% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Sincere Co., LTD's total revenue sank by 10.2% to $1B since the same quarter in the previous year.
Its net income has increased by 260.0% to $39M since the same quarter in the previous year.
Based on the above factors, Sincere Co., LTD gets an overall score of 2/5.